We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACG
3651
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
$1K ﹤0.01%
32
+15
+88% +$442
NS
3652
DELISTED
NuStar Energy L.P.
NS
$1K ﹤0.01%
55
-3,164
-98% -$81.9K
MDC
3653
DELISTED
M.D.C. Holdings, Inc.
MDC
$1K ﹤0.01%
19
-77
-80% -$2.04K
LBC
3654
DELISTED
Luther Burbank Corporation Common Stock
LBC
$1K ﹤0.01%
+100
New +$999
IMGN
3655
DELISTED
Immunogen Inc
IMGN
$1K ﹤0.01%
384
-1,226
-76% -$5.31K
JHAA
3656
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
$1K ﹤0.01%
+100
New +$1.03K
LHC.U
3657
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$1K ﹤0.01%
+100
New +$1.03K
WWE
3658
DELISTED
World Wrestling Entertainment
WWE
$1K ﹤0.01%
+10
New +$841
HARP
3659
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
+6
New +$789
ISEE
3660
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
500
-19,050
-97% -$26.6K
CYAD
3661
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1K ﹤0.01%
40
-67
-63% -$1.43K
BSMX
3662
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$1K ﹤0.01%
+100
New +$683
LMST
3663
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$1K ﹤0.01%
66
-274
-81% -$4.04K
CSII
3664
DELISTED
Cardiovascular Systems, Inc.
CSII
$1K ﹤0.01%
+37
New +$1.25K
SIOX
3665
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
50
-432
-90% -$4.3K
CHRA
3666
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$1K ﹤0.01%
+18
New +$1.28K
SWCH
3667
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$1K ﹤0.01%
100
-2,325
-96% -$20.2K
RJI
3668
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$1K ﹤0.01%
+100
New +$523
TGA
3669
DELISTED
Transglobe Energy Corp
TGA
$1K ﹤0.01%
749
-577
-44% -$1.13K
IEA
3670
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$1K ﹤0.01%
221
-1,163
-84% -$8.49K
BRG
3671
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$1K ﹤0.01%
+108
New +$1.13K
OBCI
3672
DELISTED
Ocean Bio-Chem Inc
OBCI
$1K ﹤0.01%
+285
New +$1.04K
TSC
3673
DELISTED
TriState Capital Holdings, Inc.
TSC
$1K ﹤0.01%
+51
New +$1.08K
LEJU
3674
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$1K ﹤0.01%
+56
New +$908
ARNA
3675
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1K ﹤0.01%
+32
New +$1.47K

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.